---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-002273"
form_type: "8-K"
ticker: "AZTA"
cik: "0000933974"
company_name: "Azenta, Inc."
filed_at: "2025-01-30T23:59:59+00:00"
generated_at: "2026-05-27T06:17:41.118413+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Azenta recasts historical financials to reflect B Medical Systems as discontinued operations held for sale

## Summary
- For FY2024 (12 months ended Sep 30, 2024), continuing ops revenue $573.2M, operating loss $50.6M.
- Discontinued ops (B Medical) posted net loss of $140.5M for FY2024, classified as held for sale since Nov 12, 2024.
- Recast data covers multiple prior periods to help investors isolate core Sample Management & Multiomics segments.
- Sale of B Medical is intended to simplify portfolio and focus on core revenue growth and profitability.

## SEC filing metadata
- accession: 0001437749-25-002273
- form_type: 8-K
- ticker: AZTA
- cik: 0000933974
- company_name: Azenta, Inc.
- filed_at: 2025-01-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/933974/000143774925002273/0001437749-25-002273-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/933974/000143774925002273/azta20250124_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-002273
- JSON: https://secwatch.observer/filing/0001437749-25-002273.json
- Plain text: https://secwatch.observer/filing/0001437749-25-002273.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.